Advanced Oncotherapy Plc engages in the development of proton therapy systems. It operates through the following business segments: Development of Proton Therapy-UK, Development of Proton Therapy-Switzerland, and Development of Proton Therapy-USA. The company was founded on September 15, 2005 and is headquartered in London, the United Kingdom.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company